Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfa-Blocking Agents In Inflammatory Bowel Disease Patients In Deep Remission?

摘要

Background and aims: This prospective multicenter study examined whether elevated fecal calprotectin (FC) concentrations after stopping TNF alpha-blocking therapy can predict clinical or endoscopic relapse. In addition, we evaluated the impact of histological remission on the relapse risk.